Taevas
IndiaMedical Devices
Product Registration
Market Access for Product-Registration in India
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve timely and successful market entry across diverse
Market
Global
Industry
Product-Registration
Regulator
Diverse National Health Agencies
Timeline
8-16 weeks (initial strategy)
Deliverables
Global Market Access Strategy, Regulatory Roadmaps, P&R Dossiers
What We Deliver
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
We provide in-depth analysis of regulatory landscapes across target markets, identifying critical requirements and potential hurdles for product registration. This proactive intelligence minimizes delays and optimizes your submission strategy.
Regulatory Pathway Mapping
Horizon Scanning for Policy Changes
How It Works
How It Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Initial Assessment & Scope Definition
We begin with a thorough evaluation of your product, target markets, and existing data to define the scope and objectives of your global market access strategy.
Market Snapshot
Market Overview: Global + Product-Registration
Regulatory Divergence
The increasing divergence in national regulatory requirements and health technology assessment (HTA) demands tailored strategies, making a one-size-fits-all approach obsolete for global product registration.
Value-Based Access
Payers globally are increasingly shifting towards value-based decision-making, requiring robust evidence of clinical effectiveness and economic impact beyond just safety and efficacy for market access approval.
Emerging Market Complexity
While offering significant growth potential, emerging markets present unique challenges in terms of regulatory maturity, local market dynamics, and diverse healthcare funding models, necessitating nuanced market access planning.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document detailing market entry strategies, regulatory pathways, pricing recommendations, and evidence generation plans tailored for your target markets.
Regulatory & P&R Dossier Support
Assistance in compiling and reviewing critical sections of regulatory submissions and pricing & reimbursement dossiers to meet specific country requirements.
Stakeholder Engagement Roadmap
A strategic plan outlining key stakeholders, engagement tactics, and communication messages to foster support and streamline market acceptance.
Who This Is For
Use Cases
Biotech Startup
Accelerating First-in-Class Therapy Global Launch
A biotech firm with a novel oncology therapeutic sought to launch simultaneously in the US, EU, and select APAC markets. They lacked internal expertise in navigating diverse regulatory and HTA requirements.
Outcome
Taevas developed an integrated global market access strategy, enabling successful registration and market entry in 7 key countries within 18 months, exceeding initial revenue projections.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform global regulatory hurdles into strategic market opportunities. Our expertise ensures your product achieves timely and impactful market access worldwide.
Expedited Global Market Entry
Optimized Return on Investment
Mitigated Regulatory Risks
Sustainable Market Presence